BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 12687551)

  • 1. Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathways.
    Niculescu F; Nguyen P; Niculescu T; Rus H; Rus V; Via CS
    Arthritis Rheum; 2003 Apr; 48(4):1071-9. PubMed ID: 12687551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on cell signaling immunomodulated murine peritoneal suppressor macrophages: LPS and PMA mediate the activation of RAF-1, MAPK p44 and MAPK p42 and p38 MAPK].
    Chang ZL; Lin MQ; Wang MZ; Yao Z
    Shi Yan Sheng Wu Xue Bao; 1997 Mar; 30(1):73-81. PubMed ID: 10684111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early activation of mitogen-activated protein kinase kinase, extracellular signal-regulated kinase, p38 mitogen-activated protein kinase, and c-Jun N-terminal kinase in response to binding of simian immunodeficiency virus to Jurkat T cells expressing CCR5 receptor.
    Popik W; Pitha PM
    Virology; 1998 Dec; 252(1):210-7. PubMed ID: 9875330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signaling.
    Deng C; Lu Q; Zhang Z; Rao T; Attwood J; Yung R; Richardson B
    Arthritis Rheum; 2003 Mar; 48(3):746-56. PubMed ID: 12632429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Galloyl benzamide-based compounds modulating tumour necrosis factor α-stimulated c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signalling pathways.
    Leo V; Stefanachi A; Nacci C; Leonetti F; de Candia M; Carotti A; Altomare CD; Montagnani M; Cellamare S
    J Pharm Pharmacol; 2015 Oct; 67(10):1380-92. PubMed ID: 26078032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CTL-Promoting Effects of IL-21 Counteract Murine Lupus in the Parent→F1 Graft-versus-Host Disease Model.
    Nguyen V; Rus H; Chen C; Rus V
    J Immunol; 2016 Feb; 196(4):1529-40. PubMed ID: 26792801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of mitogen-activated protein kinases in Thy-1-induced T-lymphocyte activation.
    Conrad DM; Furlong SJ; Doucette CD; Boudreau RT; Hoskin DW
    Cell Signal; 2009 Aug; 21(8):1298-307. PubMed ID: 19324083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-JUN N-terminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis.
    Schett G; Tohidast-Akrad M; Smolen JS; Schmid BJ; Steiner CW; Bitzan P; Zenz P; Redlich K; Xu Q; Steiner G
    Arthritis Rheum; 2000 Nov; 43(11):2501-12. PubMed ID: 11083274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyrrolidine dithiocarbamate-induced neuronal cell death is mediated by Akt, casein kinase 2, c-Jun N-terminal kinase, and IkappaB kinase in embryonic hippocampal progenitor cells.
    Min YK; Park JH; Chong SA; Kim YS; Ahn YS; Seo JT; Bae YS; Chung KC
    J Neurosci Res; 2003 Mar; 71(5):689-700. PubMed ID: 12584727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-sensitive and -insensitive pathways leading to JNK activation in mouse CD4(+) T-cells.
    Kirk CJ; Miller RA
    Cell Immunol; 1999 Nov; 197(2):83-90. PubMed ID: 10607425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quercitrin ameliorates the development of systemic lupus erythematosus-like disease in a chronic graft-versus-host murine model.
    Li W; Li H; Zhang M; Wang M; Zhong Y; Wu H; Yang Y; Morel L; Wei Q
    Am J Physiol Renal Physiol; 2016 Jul; 311(1):F217-26. PubMed ID: 26911849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arachidonic acid directly activates members of the mitogen-activated protein kinase superfamily in rabbit proximal tubule cells.
    Alexander LD; Cui XL; Falck JR; Douglas JG
    Kidney Int; 2001 Jun; 59(6):2039-53. PubMed ID: 11380805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T cell TRAIL promotes murine lupus by sustaining effector CD4 Th cell numbers and by inhibiting CD8 CTL activity.
    Rus V; Nguyen V; Puliaev R; Puliaeva I; Zernetkina V; Luzina I; Papadimitriou JC; Via CS
    J Immunol; 2007 Mar; 178(6):3962-72. PubMed ID: 17339497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. JNK MAPK signaling contributes in vivo to injury-induced corneal epithelial migration.
    Okada Y; Saika S; Shirai K; Yamanaka O; Kitano A; Wang Z; Yang H; Reinach P
    Ophthalmic Res; 2009; 42(4):185-92. PubMed ID: 19672126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CC chemokine receptor 2 expression in donor cells serves an essential role in graft-versus-host-disease.
    Rao AR; Quinones MP; Garavito E; Kalkonde Y; Jimenez F; Gibbons C; Perez J; Melby P; Kuziel W; Reddick RL; Ahuja SK; Ahuja SS
    J Immunol; 2003 Nov; 171(9):4875-85. PubMed ID: 14568968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The parent-into-F1 murine model in the study of lupus-like autoimmunity and CD8 cytotoxic T lymphocyte function.
    Soloviova K; Puliaiev M; Foster A; Via CS
    Methods Mol Biol; 2012; 900():253-70. PubMed ID: 22933073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV; Reynolds ER; Shao H; Grana TM; Chan TO; Andres DA; Cox AD
    Oncogene; 2000 Sep; 19(41):4685-94. PubMed ID: 11032018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies.
    Ferrer I; Blanco R; Carmona M; Puig B; Barrachina M; Gómez C; Ambrosio S
    J Neural Transm (Vienna); 2001; 108(12):1383-96. PubMed ID: 11810403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of c-Jun N-terminal kinase and activator protein 1 by receptor activator of nuclear factor kappaB.
    Lee ZH; Kwack K; Kim KK; Lee SH; Kim HH
    Mol Pharmacol; 2000 Dec; 58(6):1536-45. PubMed ID: 11093794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.